Alvotech (ALVO) Receives FDA Form 483 Following Routine Facility Inspection

How The Investment Story For Alvotech (ALVO) Is Shifting Without New Analyst Guidance

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

Alvotech shares jump after FDA accepts Entyvio biosimilar application for review (ALVO)

Alvotech Hits Critical Inflection as Biosimilar Pipeline Nears FDA Decisions

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

Alvotech Launches Public Offering, Private Placement of Ordinary Shares

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

Alvotech Prices Share Offering, Private Placement

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Fed Policy Meeting